Martin Henman

3.6k total citations
94 papers, 2.5k citations indexed

About

Martin Henman is a scholar working on Geriatrics and Gerontology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Martin Henman has authored 94 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Geriatrics and Gerontology, 20 papers in Public Health, Environmental and Occupational Health and 18 papers in Epidemiology. Recurrent topics in Martin Henman's work include Pharmaceutical Practices and Patient Outcomes (31 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Down syndrome and intellectual disability research (13 papers). Martin Henman is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (31 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Down syndrome and intellectual disability research (13 papers). Martin Henman collaborates with scholars based in Ireland, United States and United Kingdom. Martin Henman's co-authors include David C. Coleman, Derek J. Sullivan, Máire O’Dwyer, Philip McCallion, Mary McCarron, Diarmuid Shanley, Jure Peklar, Gary P. Moran, Brian J. Harrington and Christine McCreary and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Martin Henman

92 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Henman Ireland 27 774 743 692 460 262 94 2.5k
Tewodros Eguale United States 27 573 0.7× 609 0.8× 579 0.8× 222 0.5× 287 1.1× 64 2.7k
Lisa Pont Australia 23 378 0.5× 407 0.5× 571 0.8× 203 0.4× 266 1.0× 91 1.9k
Emily G. McDonald Canada 28 655 0.8× 1.2k 1.6× 245 0.4× 288 0.6× 117 0.4× 166 2.7k
B. Joseph Guglielmo United States 34 883 1.1× 910 1.2× 299 0.4× 339 0.7× 83 0.3× 96 3.1k
Juan Gestal Spain 26 223 0.3× 397 0.5× 416 0.6× 248 0.5× 252 1.0× 54 2.6k
Michael M. Kochen Germany 34 670 0.9× 201 0.3× 218 0.3× 392 0.9× 332 1.3× 115 3.3k
Pierre Olivier Lang Switzerland 29 513 0.7× 180 0.2× 1.3k 1.9× 186 0.4× 625 2.4× 128 3.2k
Yoojin Lee United States 30 595 0.8× 346 0.5× 182 0.3× 170 0.4× 157 0.6× 113 2.4k
G. Gavazzi France 28 1.3k 1.7× 547 0.7× 240 0.3× 249 0.5× 91 0.3× 143 3.2k
Fred Y. Aoki Canada 24 2.6k 3.4× 989 1.3× 201 0.3× 279 0.6× 115 0.4× 74 3.9k

Countries citing papers authored by Martin Henman

Since Specialization
Citations

This map shows the geographic impact of Martin Henman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Henman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Henman more than expected).

Fields of papers citing papers by Martin Henman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Henman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Henman. The network helps show where Martin Henman may publish in the future.

Co-authorship network of co-authors of Martin Henman

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Henman. A scholar is included among the top collaborators of Martin Henman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Henman. Martin Henman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henman, Martin, et al.. (2024). Adverse effects associated with long-term use of anticholinergics amongst older adults with intellectual disability: a longitudinal cohort study. International Journal of Pharmacy Practice. 32(Supplement_1). i21–i21.
2.
Henman, Martin, Ivana Tadić, Jelena Antić‐Stanković, et al.. (2024). Immediate and long-term effects of COVID-19 on antibiotic dispensing: increasing use of Watch antibiotics. The Journal of Infection in Developing Countries. 18(4). 504–512. 1 indexed citations
5.
Paudyal, Vibhu, Betül Okuyan, Martin Henman, et al.. (2023). Scope, content and quality of clinical pharmacy practice guidelines: a systematic review. International Journal of Clinical Pharmacy. 46(1). 56–69. 11 indexed citations
6.
Henman, Martin, Ivana Tadić, Jelena Antić‐Stanković, et al.. (2023). Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries. International Journal of Clinical Pharmacy. 45(4). 989–998. 3 indexed citations
7.
Weidmann, Anita Elaine, Cathal Cadogan, Daniela Fialová, et al.. (2023). How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy. International Journal of Clinical Pharmacy. 45(3). 781–786. 3 indexed citations
8.
Jacobsen, Ramunë, Anna Birna Almarsdóttir, Lourdes Cantarero Arévalo, et al.. (2022). Online and Blended Learning Courses for Healthcare Professionals and Policymakers on Patients’ Perspectives on Medicine: A Project Report. SHILAP Revista de lepidopterología. 10(2). 39–39. 3 indexed citations
9.
Paudyal, Vibhu, Cathal Cadogan, Daniela Fialová, et al.. (2020). Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries. Research in Social and Administrative Pharmacy. 17(8). 1507–1517. 79 indexed citations
10.
O’Dwyer, Máire, Jure Peklar, Philip McCallion, Mary McCarron, & Martin Henman. (2016). Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open. 6(4). e010505–e010505. 158 indexed citations
11.
Mil, J. W. Foppe van, Tommy Westerlund, Lawrence M. Brown, et al.. (2016). Medical care and drug-related problems: Do doctors and pharmacists speak the same language?. International Journal of Clinical Pharmacy. 38(2). 191–194. 23 indexed citations
12.
Kirby, Brian P., et al.. (2015). Hydroxycinnamic acid amide derivatives of polyamines reverse spermine-induced CNS excitation. Pharmacology Biochemistry and Behavior. 133. 57–64. 4 indexed citations
13.
Cousins, Gráinne, Rose Galvin, Michelle Flood, et al.. (2014). Potential for alcohol and drug interactions in older adults: evidence from the Irish longitudinal study on ageing. BMC Geriatrics. 14(1). 57–57. 49 indexed citations
14.
Peklar, Jure, Martin Henman, Mitja Kos, Kathryn Richardson, & Rose Anne Kenny. (2014). Concurrent Use of Drugs and Supplements in a Community-Dwelling Population Aged 50 Years or More: Potential Benefits and Risks. Drugs & Aging. 31(7). 527–540. 15 indexed citations
16.
Hughes, Carmel, Ahmed F. Hawwa, Claire Scullin, et al.. (2010). Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharmacy World & Science. 32(4). 472–487. 82 indexed citations
18.
Bernsten, Cecilia, Margarida Caramona, Grainne Crealey, et al.. (2001). Improving the Well-Being of Elderly Patients via Community Pharmacy-Based Provision of Pharmaceutical Care. Drugs & Aging. 18(1). 63–77. 165 indexed citations
19.
Coleman, David C., et al.. (1993). Oral Candida in HIV Infection and AIDS: New Perspectives/New Approaches. Critical Reviews in Microbiology. 19(2). 61–82. 117 indexed citations
20.
Henman, Martin, Guy Leach, & I.L. Naylor. (1979). Production of prostaglandin-like materials by rat tail skin in response to injury [proceedings].. PubMed Central. 66(3). 448P–448P. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026